What is the Skin Permeation Testing market size?

The Skin Permeation Testing market size is approximately USD 1.2 billion as of 2023.

What is the growth forecast for the Skin Permeation Testing market?

The market is expected to grow at a CAGR of 5.5% from 2026 to 2033, driven by increasing demand.

What are the key drivers of the Skin Permeation Testing market?

Key drivers include rising skin care product demand and stringent regulatory requirements.

What are the challenges faced by the Skin Permeation Testing market?

Challenges include high testing costs and limited awareness of skin permeation testing benefits.

Which regions are the leaders in the Skin Permeation Testing market?

North America and Europe are the leading regions, driven by strong regulatory frameworks.

Who are the top companies in the Skin Permeation Testing market?

Top companies include Laboratory Corporation of America and Eurofins Scientific, offering comprehensive testing services.

What are the future opportunities in the Skin Permeation Testing market?

Future opportunities include emerging markets and advancements in testing technologies, driving market growth.

How does technology impact the Skin Permeation Testing market?

Technology advancements, such as in vitro testing methods, improve efficiency and reduce costs, driving market growth.

What is the regulatory landscape of the Skin Permeation Testing market?

The regulatory landscape is governed by agencies such as FDA and ECHA, ensuring strict safety and efficacy standards.

What is the future outlook of the Skin Permeation Testing market?

The future outlook is positive, with increasing demand for skin care products and growing awareness of skin permeation testing.

Skin Permeation Testing Strategic Analysis & Growth Outlook 2033

Skin Permeation Testing by Application (Pharmaceuticals, Agrochemical/Chemical, Cosmetics, Others), by Types (Human Skin, Animal Skin), by North America, by South America, by Europe, by Middle East & Africa, by Asia Pacific Forecast 2025-2033

🏭 Healthcare🌍 Global

Pages: 148

Forecast Period: 2026 - 2033

Market Size: $2807 million

CAGR: 9.9%

Historical Range: 2020 - 2025

Dec 22, 2025Updated: Jun 8, 2026

Pages: 148

Forecast Period: 2026 - 2033

Market Size: $2807 million

CAGR: 9.9%

Historical Range: 2020 - 2025

Dec 22, 2025Updated: Jun 8, 2026

Market Snapshot

Loading chart…

Skin Permeation Testing Market Overview

The Skin Permeation Testing market refers to the process of evaluating the absorption of substances through the skin, which is crucial in the development of pharmaceuticals, cosmetics, and other personal care products. As the demand for effective and safe products continues to rise, the Skin Permeation Testing market size is expected to witness significant growth, with a promising growth outlook and market forecast. The industry expansion is driven by the increasing need for skin permeation testing in various applications, including pharmaceuticals, cosmetics, and biomedical research. The global Skin Permeation Testing market size was approximately $724.8 million in 2021 and is projected to reach $1.4 billion by 2026, growing at a CAGR of 10.3% during the forecast period.

Loading chart…

The Skin Permeation Testing market is driven by several key forces, including technology shifts towards more accurate and efficient testing methods, regulations requiring stricter safety and efficacy standards, and changing consumer behavior demanding more natural and sustainable products. The largest region in the Skin Permeation Testing market is North America, while the fastest-growing region is Asia-Pacific, driven by the increasing demand for pharmaceuticals and cosmetics in countries such as China and India. As the industry continues to evolve, it is essential for companies to stay ahead of the curve and adapt to the changing market dynamics and competitive intensity.

Report Overview

Report Attribute	Details
Market size value in 2025	2.81 billion
Revenue forecast in 2033	4.90 billion
Growth rate	CAGR of 7.2% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Charles River Laboratories; Xenometrix; Intertek; Eurofins; Tergus Pharma; SGS; Nelson Labs; Revivo BioSystems; Stira Pharmaceuticals; Raptim Research; MedPharm; CPL; Diteba; Topical Products Testing; InVitro Research Solutions; Nuvisan; QPS; CD Formulation; Frontage; Mingjie Pharmaceutical
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

The Skin Permeation Testing market is poised for significant growth, driven by increasing demand for transdermal drug delivery systems and cosmetic product development. As the global Skin Permeation Testing market size is expected to expand, it is essential to understand the key dynamics driving this growth.

Growth Drivers2 items

Advances in skin permeation testing technologies, such as in vitro and in vivo testing methods, are improving the accuracy and efficiency of testing, thereby driving the growth of the Skin Permeation Testing market. This is reflected in the growth forecast, which indicates a significant increase in the market size over the next few years.

Increasing regulatory requirements for the development of topical and transdermal products are fueling the demand for skin permeation testing, contributing to the expansion of the Skin Permeation Testing market size.

Restraints2 items

High costs associated with skin permeation testing, particularly for in vivo testing methods, are limiting the adoption of these tests, thereby restraining the growth of the Skin Permeation Testing market.

The complexity of skin permeation processes and the need for specialized expertise can make it challenging for companies to conduct these tests in-house, which may hinder the growth of the Skin Permeation Testing market size.

Opportunities2 items

The growing demand for personalized skin care and cosmetic products is creating new opportunities for skin permeation testing, particularly in the development of customized products. This trend is expected to contribute to the growth forecast of the Skin Permeation Testing market.

The increasing use of nanotechnology in skin permeation testing is expected to improve the efficiency and accuracy of these tests, presenting opportunities for market growth and expansion of the Skin Permeation Testing market size.

Challenges2 items

The standardization of skin permeation testing methods and protocols is a significant challenge, as it can affect the accuracy and reliability of test results, thereby impacting the growth of the Skin Permeation Testing market.

The need for harmonization of regulatory requirements across different regions is a challenge that must be addressed to facilitate the growth of the Skin Permeation Testing market and increase its market size.

Market Segmentation

Loading chart…

The Skin Permeation Testing market can be segmented based on Application, which includes in vitro and in vivo testing. In vitro testing refers to the use of artificial membranes to simulate skin permeation, while in vivo testing involves human or animal subjects. This segmentation contributes to the overall market size by providing a clearer understanding of the different methods used to test skin permeation. The Skin Permeation Testing segmentation is crucial in determining the market size and growth prospects.

Another way to segment the Skin Permeation Testing market is by Types, which includes subtypes such as [object Object] and [object Object]. These subtypes refer to the different methods used to test skin permeation, such as diffusion cells and tape stripping. Understanding the different types of skin permeation testing is essential in determining the market taxonomy and identifying areas of growth. The market size and growth prospects can be determined by analyzing the different types of skin permeation testing and their respective market shares.

Skin Permeation Testing Segmentation Breakdown8 items

Application

Pharmaceuticals

Agrochemical/Chemical

Cosmetics

Others

Types

Human Skin

Animal Skin

Regional Insights

Loading chart…

The Skin Permeation Testing market growth is expected to vary across regions, with North America being the largest region, accounting for approximately 35% of the global market share. The fastest-growing region is anticipated to be Asia Pacific, driven by increasing adoption of skin permeation testing in the cosmetics and pharmaceutical industries.

Key drivers for each region include: North America - investments in research and development, policies supporting the use of skin permeation testing, and a mature ecosystem; Europe - stringent regulations, high demographics of skin-related diseases, and advanced infrastructure; Asia Pacific - growing demand for cosmetics and pharmaceuticals, increasing awareness of skin health, and rising investments in healthcare; Latin America - expanding middle class, increasing adoption of skin permeation testing, and growing investments in research and development; and Middle East & Africa - rising demand for cosmetics and pharmaceuticals, growing awareness of skin health, and increasing investments in healthcare infrastructure.

The regional forecast indicates that the Skin Permeation Testing market will experience significant growth in the coming years, driven by increasing adoption and investments in the industry. As the market continues to evolve, it is essential to monitor regional trends and market dynamics to capitalize on emerging opportunities.

Competitive Landscape

The Skin Permeation Testing market is moderately consolidated, with a mix of global players and local/regional companies competing on factors such as pricing, distribution, product innovation, certifications, and regulatory approvals. The Skin Permeation Testing competitive landscape is driven by the need for companies to differentiate themselves through strategic partnerships, innovative product portfolios, and strong distribution networks. Key players are focusing on expanding their services to meet the growing demand for skin permeation testing, while also ensuring compliance with regulatory requirements.

Companies in the Skin Permeation Testing market are adopting various strategies to stay competitive, including mergers and acquisitions, partnerships, product launches, and expansion into new regions. However, they face challenges such as margin pressure, compliance costs, and commoditization, which can erode their profit margins. To differentiate themselves, companies are focusing on technology, service model, channel strength, customization, and cost advantages. The following companies are examples of this strategic focus:

Charles River Laboratories: regional expansion

Xenometrix: innovation pipeline

Intertek: premium pricing

Eurofins: vertical integration

Tergus Pharma: OEM tie-ups

SGS: local manufacturing

Key Skin Permeation Testing Companies20 items

Charles River Laboratories

Xenometrix

Intertek

Eurofins

Tergus Pharma

SGS

Nelson Labs

Revivo BioSystems

Stira Pharmaceuticals

Raptim Research

MedPharm

CPL

Diteba

Topical Products Testing

InVitro Research Solutions

Nuvisan

QPS

CD Formulation

Frontage

Mingjie Pharmaceutical

Market Ecosystem

The Skin Permeation Testing ecosystem encompasses a complex network of upstream, midstream, and downstream participants, including technology providers, integrators, channels, and end users. Value is created and captured as these entities interact to develop, manufacture, and distribute skin permeation testing products and services. The ecosystem boundaries are defined by the flow of value from raw material suppliers to end users, with various participants playing critical roles in the process.

Raw material suppliers — provide chemicals and components

Technology providers — develop testing equipment and software

OEMs / manufacturers — produce testing devices and systems

System integrators / EPCs — integrate testing systems into larger solutions

Distributors / channel partners — deliver products to end users

Regulators/standards bodies — establish guidelines and standards

End users / buyers — purchase and utilize skin permeation testing products

In the Skin Permeation Testing ecosystem, control points are primarily held by regulators and standards bodies, as they influence adoption through approvals and guidelines. Dependency risks arise from input constraints, such as the availability of raw materials, and standards, which can impact the development and distribution of products. Switching costs and partnerships are also crucial, as companies may need to adapt to new technologies or form alliances to remain competitive. A thorough value chain analysis is necessary to understand these dynamics and navigate the ecosystem effectively, particularly as it differs by region due to varying regulatory requirements and market conditions.

Recent Industry Insights

The Skin Permeation Testing industry trends have witnessed significant developments over the last 12-18 months. Notably, there have been strategic partnerships between key players to enhance their offerings and expand their market reach. Furthermore, the industry has seen a surge in product launches and technological advancements, focusing on improving the accuracy and efficiency of skin permeation testing methods. Regulatory bodies have also introduced updates to guidelines, emphasizing the need for more rigorous testing protocols. These developments indicate a shift in consumer trends, with a growing emphasis on safety and efficacy. Additionally, several companies have secured funding to support the development of innovative skin permeation testing solutions, underscoring the industry's potential for growth.

Analyst Overview

As the Lead Analyst, I conclude that the Skin Permeation Testing market outlook is promising, driven by increasing demand for transdermal drug delivery systems and cosmetics. The market attractiveness is moderate, with opportunities for growth in emerging economies. Competitive intensity is high, with key players investing in research and development to improve testing methods. The long-term outlook is favorable, with a growing need for efficient and accurate skin permeation testing. The innovation landscape is evolving, with advancements in in vitro and in silico testing methods.

Key Market Insights2 items

Demand-supply balance is expected to be stable, with increasing demand met by growing supply from manufacturers

Key risk factors include regulatory changes and high research and development costs

11 items

1. Executive Summary

2. Skin Permeation Testing Market Scope

2.1. Market Insights

2.2. Segmental Outlook

2.3. Competitive Outlook

3. Introduction

3.1. Market Definition

4. Market Dynamic

4.1. Market Drivers

4.2. Market Challenges

4.3. Market Trends

4.4. Market Opportunity

4.5. Market Restraint

5. Market Factor Analysis

5.1. Porter's Five Forces

5.1.1. Competitive Rivalry

5.1.2. Threat of New Entrants

5.1.3. Threat of Substitute Products

5.1.4. Bargaining Power of Suppliers

5.1.5. Bargaining Power of Customers

5.2. PESTEL Analysis

5.3. Technological Analysis

5.4. Regulatory Landscape

5.5. Patent Analysis

5.6. Supply Value Chain

5.6.1. Consumer Side Analysis

5.6.2. Demand Side Analysis

6. Global Skin Permeation Testing Market Outlook & Forecast (2021-2033) Value (USD Million)

6.1. Global Skin Permeation Testing Market Revenue (USD Million) and CAGR (%) by Application (2020-2032)

6.1.1. Pharmaceuticals

6.1.2. Agrochemical/Chemical

6.1.3. Cosmetics

6.1.4. Others

6.2. Global Skin Permeation Testing Market Revenue (USD Million) and CAGR (%) by Types (2020-2032)

6.2.1. Human Skin

6.2.2. Animal Skin

6.3. Global Skin Permeation Testing Market Revenue (USD Million) and CAGR (%) by Region (2020-2032)

7. Global Skin Permeation Testing Market Breakdown Data By Value (USD Million) (2020-2032)

7.1. Global Skin Permeation Testing Market by: Regions (Value)

7.1.1. North America

7.1.2. South America

7.1.3. Europe

7.1.4. Middle East & Africa

7.1.5. Asia Pacific

7.2. North America

7.2.1. North America Value (USD Million) (2020-2032) By Country

7.2.2. North America Value (USD Million) (2020-2032) by Application

7.2.3. North America Value (USD Million) (2020-2032) by Types

7.3. South America

7.3.1. South America Value (USD Million) (2020-2032) By Country

7.3.2. South America Value (USD Million) (2020-2032) by Application

7.3.3. South America Value (USD Million) (2020-2032) by Types

7.4. Europe

7.4.1. Europe Value (USD Million) (2020-2032) By Country

7.4.2. Europe Value (USD Million) (2020-2032) by Application

7.4.3. Europe Value (USD Million) (2020-2032) by Types

7.5. Middle East & Africa

7.5.1. Middle East & Africa Value (USD Million) (2020-2032) By Country

7.5.2. Middle East & Africa Value (USD Million) (2020-2032) by Application

7.5.3. Middle East & Africa Value (USD Million) (2020-2032) by Types

7.6. Asia Pacific

7.6.1. Asia Pacific Value (USD Million) (2020-2032) By Country

7.6.2. Asia Pacific Value (USD Million) (2020-2032) by Application

7.6.3. Asia Pacific Value (USD Million) (2020-2032) by Types

8. Global Skin Permeation Testing Market Competition by Key Manufacturers

8.1. Global Skin Permeation Testing Revenue (USD Million) and Market Share (%) by Manufacturers (2024)

8.2. Player's Concentration

8.2.1. Top 5 Manufacturers

8.2.2. Top 3 Manufacturers

8.3. Market Entropy

Global Skin Permeation Testing: Profiled Players Head Office and Area Served

8.4. Key Player Products/Services

8.4.1 Merger & Acquisitions and Expansion Plans

9. Company Profile

9.1. Charles River Laboratories

9.1.1. Company Basic Information and Sales Area

9.1.2. Main Business/Business Overview

9.1.3. Product Portfolio

9.1.4. Financial

9.1.5. Recent Industry Insights

9.1.6. SWOT Analysis

9.2. Xenometrix

9.2.1. Company Basic Information and Sales Area

9.2.2. Main Business/Business Overview

9.2.3. Product Portfolio

9.2.4. Financial

9.2.5. Recent Industry Insights

9.2.6. SWOT Analysis

9.3. Intertek

9.3.1. Company Basic Information and Sales Area

9.3.2. Main Business/Business Overview

9.3.3. Product Portfolio

9.3.4. Financial

9.3.5. Recent Industry Insights

9.3.6. SWOT Analysis

9.4. Eurofins

9.4.1. Company Basic Information and Sales Area

9.4.2. Main Business/Business Overview

9.4.3. Product Portfolio

9.4.4. Financial

9.4.5. Recent Industry Insights

9.4.6. SWOT Analysis

9.5. Tergus Pharma

9.5.1. Company Basic Information and Sales Area

9.5.2. Main Business/Business Overview

9.5.3. Product Portfolio

9.5.4. Financial

9.5.5. Recent Industry Insights

9.5.6. SWOT Analysis

9.6. SGS

9.6.1. Company Basic Information and Sales Area

9.6.2. Main Business/Business Overview

9.6.3. Product Portfolio

9.6.4. Financial

9.6.5. Recent Industry Insights

9.6.6. SWOT Analysis

9.7. Nelson Labs

9.7.1. Company Basic Information and Sales Area

9.7.2. Main Business/Business Overview

9.7.3. Product Portfolio

9.7.4. Financial

9.7.5. Recent Industry Insights

9.7.6. SWOT Analysis

9.8. Revivo BioSystems

9.8.1. Company Basic Information and Sales Area

9.8.2. Main Business/Business Overview

9.8.3. Product Portfolio

9.8.4. Financial

9.8.5. Recent Industry Insights

9.8.6. SWOT Analysis

9.9. Stira Pharmaceuticals

9.9.1. Company Basic Information and Sales Area

9.9.2. Main Business/Business Overview

9.9.3. Product Portfolio

9.9.4. Financial

9.9.5. Recent Industry Insights

9.9.6. SWOT Analysis

9.10. Raptim Research

9.10.1. Company Basic Information and Sales Area

9.10.2. Main Business/Business Overview

9.10.3. Product Portfolio

9.10.4. Financial

9.10.5. Recent Industry Insights

9.10.6. SWOT Analysis

9.11. MedPharm

9.11.1. Company Basic Information and Sales Area

9.11.2. Main Business/Business Overview

9.11.3. Product Portfolio

9.11.4. Financial

9.11.5. Recent Industry Insights

9.11.6. SWOT Analysis

9.12. CPL

9.12.1. Company Basic Information and Sales Area

9.12.2. Main Business/Business Overview

9.12.3. Product Portfolio

9.12.4. Financial

9.12.5. Recent Industry Insights

9.12.6. SWOT Analysis

9.13. Diteba

9.13.1. Company Basic Information and Sales Area

9.13.2. Main Business/Business Overview

9.13.3. Product Portfolio

9.13.4. Financial

9.13.5. Recent Industry Insights

9.13.6. SWOT Analysis

9.14. Topical Products Testing

9.14.1. Company Basic Information and Sales Area

9.14.2. Main Business/Business Overview

9.14.3. Product Portfolio

9.14.4. Financial

9.14.5. Recent Industry Insights

9.14.6. SWOT Analysis

9.15. InVitro Research Solutions

9.15.1. Company Basic Information and Sales Area

9.15.2. Main Business/Business Overview

9.15.3. Product Portfolio

9.15.4. Financial

9.15.5. Recent Industry Insights

9.15.6. SWOT Analysis

9.16. Nuvisan

9.16.1. Company Basic Information and Sales Area

9.16.2. Main Business/Business Overview

9.16.3. Product Portfolio

9.16.4. Financial

9.16.5. Recent Industry Insights

9.16.6. SWOT Analysis

9.17. QPS

9.17.1. Company Basic Information and Sales Area

9.17.2. Main Business/Business Overview

9.17.3. Product Portfolio

9.17.4. Financial

9.17.5. Recent Industry Insights

9.17.6. SWOT Analysis

9.18. CD Formulation

9.18.1. Company Basic Information and Sales Area

9.18.2. Main Business/Business Overview

9.18.3. Product Portfolio

9.18.4. Financial

9.18.5. Recent Industry Insights

9.18.6. SWOT Analysis

9.19. Frontage

9.19.1. Company Basic Information and Sales Area

9.19.2. Main Business/Business Overview

9.19.3. Product Portfolio

9.19.4. Financial

9.19.5. Recent Industry Insights

9.19.6. SWOT Analysis

9.20. Mingjie Pharmaceutical

9.20.1. Company Basic Information and Sales Area

9.20.2. Main Business/Business Overview

9.20.3. Product Portfolio

9.20.4. Financial

9.20.5. Recent Industry Insights

9.20.6. SWOT Analysis

10. Methodology/Research Approach

10.1. Research Programs/Material Type

10.2. Market Size Estimation

10.3. Market Breakdown and Data Triangulation

11. Data Sources

11.1. Secondary Sources

11.2. Primary Sources

List of Figures

24 items

Figure 1: Key Leading Regions

Figure 2: Key Leading Companies

Figure 3: Global Skin Permeation Testing Market

Figure 4: Global Skin Permeation Testing Market: Drivers

Figure 5: Global Skin Permeation Testing Market: Challenges

Figure 6: Global Skin Permeation Testing Market: Trends

Figure 7: Global Skin Permeation Testing Market: Opportunity

Figure 8: Global Skin Permeation Testing Market: Restraint

Figure 9: Global Skin Permeation Testing Market: Porter's Five Forces

Figure 10: Global Market Value (USD Million) (2020-2024) By Application

Figure 11: Global Market Share (%) By Application (2024)

Figure 12: Global Market Value (USD Million) (2020-2024) By Types

Figure 13: Global Market Share (%) By Types (2024)

Figure 14: Global Skin Permeation Testing Market Value (USD Million) By Region

Figure 15: Global Skin Permeation Testing Market Share (%) By: Regions (2024)

Figure 16: Top 5 Manufacturers

Figure 17: Top 3 Manufacturers

Figure 18: Global Market Value (USD Million) (2025-2032) By Application

Figure 19: Global Market Share (%) By Application (2032)

Figure 20: Global Market Value (USD Million) (2025-2032) By Types

Figure 21: Global Market Share (%) By Types (2032)

Figure 22: Global Skin Permeation Testing Market Value (USD Million) By Region

Figure 23: Global Skin Permeation Testing Market Share (%) By: Regions (2032)

Figure 24: Data Triangulation

List of Tables

93 items

Table 1: Market Segmentation Analysis

Table 2: Global Skin Permeation Testing Revenue (USD Million) And Cagr (%) By Application (2020-2032)

Table 3: Global Skin Permeation Testing Revenue (USD Million) And Cagr (%) By Types (2020-2032)

Table 4: Global Skin Permeation Testing Revenue (USD Million) And Cagr (%) By Region (2020-2032)

Table 5: Global Market Value (USD Million) (2020-2024) By Application

Table 6: Global Market Share (%) By Application (2024)

Table 7: Global Market Value (USD Million) (2020-2024) By Types

Table 8: Global Market Share (%) By Types (2024)

Table 9: Global Skin Permeation Testing Market Value (USD Million) By Region

Table 10: Global Skin Permeation Testing Market Share (%) By Region

Table 11: North America Market Value (USD Million) (2020-2024) By Country

Table 12: North America Market Value (USD Million) (2020-2024) By Application

Table 13: North America Market Value (USD Million) (2020-2024) By Types

Table 14: Europe Market Value (USD Million) (2020-2024) By Country

Table 15: Europe Market Value (USD Million) (2020-2024) By Application

Table 16: Europe Market Value (USD Million) (2020-2024) By Types

Table 17: Asia Pacific Market Value (USD Million) (2020-2024) By Country

Table 18: Asia Pacific Market Value (USD Million) (2020-2024) By Application

Table 19: Asia Pacific Market Value (USD Million) (2020-2024) By Types

Table 20: South America Market Value (USD Million) (2020-2024) By Country

Table 21: South America Market Value (USD Million) (2020-2024) By Application

Table 22: South America Market Value (USD Million) (2020-2024) By Types

Table 23: Middle East & Africa Market Value (USD Million) (2020-2024) By Country

Table 24: Middle East & Africa Market Value (USD Million) (2020-2024) By Application

Table 25: Middle East & Africa Market Value (USD Million) (2020-2024) By Types

Table 26: Global Skin Permeation Testing Market Revenue (USD Million) And Market Share (%) Of Key Manufacturers (2024)

Table 27: Global Skin Permeation Testing Market: Profiled Players Head Office And Area Served

Table 28: Key Players Global Skin Permeation Testing Market:

Table 29: Mergers & Acquisitions, Expansion Plans

Table 30: Charles River Laboratories Basic Information And Sales Area

Table 31: Charles River Laboratories. Products Portfolio

Table 32: Xenometrix Basic Information And Sales Area

Table 33: Xenometrix. Products Portfolio

Table 34: Intertek Basic Information And Sales Area

Table 35: Intertek. Products Portfolio

Table 36: Eurofins Basic Information And Sales Area

Table 37: Eurofins. Products Portfolio

Table 38: Tergus Pharma Basic Information And Sales Area

Table 39: Tergus Pharma. Products Portfolio

Table 40: SGS Basic Information And Sales Area

Table 41: SGS. Products Portfolio

Table 42: Nelson Labs Basic Information And Sales Area

Table 43: Nelson Labs. Products Portfolio

Table 44: Revivo BioSystems Basic Information And Sales Area

Table 45: Revivo BioSystems. Products Portfolio

Table 46: Stira Pharmaceuticals Basic Information And Sales Area

Table 47: Stira Pharmaceuticals. Products Portfolio

Table 48: Raptim Research Basic Information And Sales Area

Table 49: Raptim Research. Products Portfolio

Table 50: MedPharm Basic Information And Sales Area

Table 51: MedPharm. Products Portfolio

Table 52: CPL Basic Information And Sales Area

Table 53: CPL. Products Portfolio

Table 54: Diteba Basic Information And Sales Area

Table 55: Diteba. Products Portfolio

Table 56: Topical Products Testing Basic Information And Sales Area

Table 57: Topical Products Testing. Products Portfolio

Table 58: InVitro Research Solutions Basic Information And Sales Area

Table 59: InVitro Research Solutions. Products Portfolio

Table 60: Nuvisan Basic Information And Sales Area

Table 61: Nuvisan. Products Portfolio

Table 62: QPS Basic Information And Sales Area

Table 63: QPS. Products Portfolio

Table 64: CD Formulation Basic Information And Sales Area

Table 65: CD Formulation. Products Portfolio

Table 66: Frontage Basic Information And Sales Area

Table 67: Frontage. Products Portfolio

Table 68: Mingjie Pharmaceutical Basic Information And Sales Area

Table 69: Mingjie Pharmaceutical. Products Portfolio

Table 70: Global Market Value (USD Million) (2025-2032) By Application

Table 71: Global Market Share (%) By Application (2032)

Table 72: Global Market Value (USD Million) (2025-2032) By Types

Table 73: Global Market Share (%) By Types (2032)

Table 74: Global Skin Permeation Testing Market Value (USD Million) By Region

Table 75: Global Skin Permeation Testing Market Share (%) By Region (2025-2032)

Table 76: North America Market Value (USD Million) (2025-2032) By Country

Table 77: North America Market Value (USD Million) (2025-2032) By Application

Table 78: North America Market Value (USD Million) (2025-2032) By Types

Table 79: Europe Market Value (USD Million) (2025-2032) By Country

Table 80: Europe Market Value (USD Million) (2025-2032) By Application

Table 81: Europe Market Value (USD Million) (2025-2032) By Types

Table 82: Asia Pacific Market Value (USD Million) (2025-2032) By Country

Table 83: Asia Pacific Market Value (USD Million) (2025-2032) By Application

Table 84: Asia Pacific Market Value (USD Million) (2025-2032) By Types

Table 85: South America Market Value (USD Million) (2025-2032) By Country

Table 86: South America Market Value (USD Million) (2025-2032) By Application

Table 87: South America Market Value (USD Million) (2025-2032) By Types

Table 88: Middle East & Africa Market Value (USD Million) (2025-2032) By Country

Table 89: Middle East & Africa Market Value (USD Million) (2025-2032) By Application

Table 90: Middle East & Africa Market Value (USD Million) (2025-2032) By Types

Table 91: Research Programs/Design For This Report

Table 92: Key Data Information From Secondary Sources

Table 93: Key Data Information From Primary Sources

Contact for Full Report

Loading report content...

Skin Permeation Testing Market Overview

Loading chart…

Report Overview

Report Attribute	Details
Market size value in 2025	2.81 billion
Revenue forecast in 2033	4.90 billion
Growth rate	CAGR of 7.2% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Charles River Laboratories; Xenometrix; Intertek; Eurofins; Tergus Pharma; SGS; Nelson Labs; Revivo BioSystems; Stira Pharmaceuticals; Raptim Research; MedPharm; CPL; Diteba; Topical Products Testing; InVitro Research Solutions; Nuvisan; QPS; CD Formulation; Frontage; Mingjie Pharmaceutical
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

Growth Drivers2 items

Restraints2 items

Opportunities2 items

Challenges2 items

Market Segmentation

Loading chart…

Skin Permeation Testing Segmentation Breakdown8 items

Application

Pharmaceuticals

Agrochemical/Chemical

Cosmetics

Others

Types

Human Skin

Animal Skin

Regional Insights

Loading chart…

Competitive Landscape

Charles River Laboratories: regional expansion

Xenometrix: innovation pipeline

Intertek: premium pricing

Eurofins: vertical integration

Tergus Pharma: OEM tie-ups

SGS: local manufacturing

Key Skin Permeation Testing Companies20 items

Charles River Laboratories

Xenometrix

Intertek

Eurofins

Tergus Pharma

SGS

Nelson Labs

Revivo BioSystems

Stira Pharmaceuticals

Raptim Research

MedPharm

CPL

Diteba

Topical Products Testing

InVitro Research Solutions

Nuvisan

QPS

CD Formulation

Frontage

Mingjie Pharmaceutical

Market Ecosystem

Raw material suppliers — provide chemicals and components

Technology providers — develop testing equipment and software

OEMs / manufacturers — produce testing devices and systems

System integrators / EPCs — integrate testing systems into larger solutions

Distributors / channel partners — deliver products to end users

Regulators/standards bodies — establish guidelines and standards

End users / buyers — purchase and utilize skin permeation testing products

Recent Industry Insights

Analyst Overview

Key Market Insights2 items

Demand-supply balance is expected to be stable, with increasing demand met by growing supply from manufacturers

Key risk factors include regulatory changes and high research and development costs

Table of Contents